Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H21N3S |
| Molecular Weight | 323.455 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCN(CC1)C2=NC3=CC=CC=C3SC4=CC=C(C)C=C24
InChI
InChIKey=IOEPXYJOHIZYGQ-UHFFFAOYSA-N
InChI=1S/C19H21N3S/c1-14-7-8-17-15(13-14)19(22-11-9-21(2)10-12-22)20-16-5-3-4-6-18(16)23-17/h3-8,13H,9-12H2,1-2H3
| Molecular Formula | C19H21N3S |
| Molecular Weight | 323.455 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A double-blind evaluation of metiapine in hospitalized acute schizophrenics. | 1975-12 |
|
| A controlled comparison of metiapine and chlorpromazine in chronic schizophrenia. | 1973-10 |
|
| Metiapine in acute schizophrenic patients. | 1973-07 |
|
| Metiapine: the evaluation of the antipsychotic properties of a new neuroleptic. A pilot study. | 1973-07 |
|
| Metiapine: a new antipsychotic agent. | 1970-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28349512
Metiapine: capsule, range 100 mg/day to 600 mg/day
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 06:53:36 GMT 2025
by
admin
on
Wed Apr 02 06:53:36 GMT 2025
|
| Record UNII |
775D6D91J8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2106892
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
DTXSID7020891
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
100000080892
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
22047
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
2669
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
C005179
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
C90761
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
Metiapine
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
775D6D91J8
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
5800-19-1
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY | |||
|
SUB08882MIG
Created by
admin on Wed Apr 02 06:53:36 GMT 2025 , Edited by admin on Wed Apr 02 06:53:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |